← Back to headlines

Bosnia and Herzegovina Approves Controversial Drug Remifentanil for Use
Bosnia and Herzegovina's Commission for the Suppression of Drug Abuse has approved remifentanil for use, reclassifying it from a completely banned substance to one under strict supervision.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.



